Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioanalysis|January 22, 2013
Characterization of critical reagents in ligand-binding assays: enabling robust bioanalytical methods and lifecycle managementBrian J Geist, Adrienne Clements Egan, Tong-Yuan Yang, et al.
The AAPS Journal|October 25, 2017
Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation StrategiesZhandong Don Zhong, Adrienne Clements-Egan, Boris Gorovits, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 25, 2010
Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeuticsDeborah Finco, Daniel Baltrukonis, Adrienne Clements-Egan, et al.
The AAPS Journal|April 18, 2019
Report on the AAPS Immunogenicity Guidance ForumHeather Myler, Boris Gorovits, Kelli Phillips, et al.
The AAPS Journal|November 8, 2017
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic DevelopmentLi Xue, Adrienne Clements-Egan, Lakshmi Amaravadi, et al.
The AAPS Journal|January 30, 2016
Pre-existing Antibody: Biotherapeutic Modality-Based ReviewBoris Gorovits, Adrienne Clements-Egan, Mary Birchler, et al.
The AAPS Journal|March 15, 2012
Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagentsDenise M O'Hara, Valerie Theobald, Adrienne Clements Egan, et al.
The AAPS Journal|June 25, 2025
Pharmacokinetics and Pharmacodynamics of Nomlabofusp in Non-clinical Studies of Friedreich's AtaxiaFlavia De Toni, Vanessa Ragaglia, Devin Schecter, et al.
Pageof 2